190 related articles for article (PubMed ID: 319891)
1. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
2. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients.
Grosser N; Thompson DM
Int J Cancer; 1976 Jul; 18(1):58-66. PubMed ID: 59711
[TBL] [Abstract][Full Text] [Related]
3. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
O'Connor R; MacFarlane JK; Murray D; Thomson DM
Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586
[TBL] [Abstract][Full Text] [Related]
4. The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
Lopez M; O'Connor R; MacFarlane JK; Thomson DM
Br J Cancer; 1978 Dec; 38(6):660-73. PubMed ID: 369585
[TBL] [Abstract][Full Text] [Related]
5. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
Harding MW; Yang TJ
Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
[TBL] [Abstract][Full Text] [Related]
6. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
7. Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibody.
Marti JH; Grosser N; Thomson DM
Int J Cancer; 1976 Jul; 18(1):48-57. PubMed ID: 947860
[TBL] [Abstract][Full Text] [Related]
8. Analysis of sera from patients with breast cancer for blocking and induction of leukocyte adherence inhibition.
Tanaka F; Sawada K; Yonemoto RH
Gan; 1980 Oct; 71(5):589-95. PubMed ID: 7014342
[TBL] [Abstract][Full Text] [Related]
9. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
Tataryn DN; MacFarlane JK; Murray D; Thomson DM
Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
Holán V; Síbl O; Hasek M
Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
[TBL] [Abstract][Full Text] [Related]
11. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
[TBL] [Abstract][Full Text] [Related]
12. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients.
Fujisawa T; Waldman SR; Yonemoto RH
Cancer; 1977 Feb; 39(2):506-13. PubMed ID: 65207
[TBL] [Abstract][Full Text] [Related]
15. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG
J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
Fritze D; Kaufmann M; Drings P; Fedra G
Oncology; 1978; 35(6):242-5. PubMed ID: 370704
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
MacFarlane JK; Thomson DM; Phelan K; Shenouda G; Scanzano R
Cancer; 1982 Mar; 49(6):1185-93. PubMed ID: 7037158
[TBL] [Abstract][Full Text] [Related]
18. Amplification of lymph node cell tube leukocyte adherence inhibition (LAI) reactivity by leukocyte adherence inhibition factor (LAIF).
Harding MW; Yang TJ
Cell Immunol; 1984 Aug; 87(1):206-16. PubMed ID: 6204773
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte adherence inhibition (LAI) in rats bearing transplantable syngeneic tumors of different immunogenicity.
Tank B; Marquet RL; Vennemans E; Westbroek DL
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1539-46. PubMed ID: 3913605
[TBL] [Abstract][Full Text] [Related]
20. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]